Home / Norethisterone and Estrogen / Canada
CA ATC G03FA01 · updated 2 Nov 2026
Norethisterone and Estrogen shortage in Canada
Is there a Norethisterone and Estrogen shortage in Canada?
Yes. As of 2 Nov 2026, 1 Norethisterone and Estrogen product is reported short in Canada. The company estimate for the return is 28 Feb 2027. Main reason: increased demand.
Also short in Sweden. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | ESTALIS 250/50 MCG (8TTSM) anticipated | SANDOZ CANADA INCORPORATED | 15 Jan 2027 | 28 Feb 2027 | Increased demand Demand increase for the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.